136 related articles for article (PubMed ID: 37277286)
1. Optimizing surface mould brachytherapy for treatment of nasal basal cell carcinoma using customized applicators.
Barnes EA; Tsao MN; Taggar AS; Ravi A; Paudel MR
Brachytherapy; 2023; 22(5):665-672. PubMed ID: 37277286
[TBL] [Abstract][Full Text] [Related]
2. A dosimetric comparison of CT- and photogrammetry- generated 3D printed HDR brachytherapy surface applicators.
Bridger CA; Reich PD; Caraça Santos AM; Douglass MJJ
Phys Eng Sci Med; 2022 Mar; 45(1):125-134. PubMed ID: 35020174
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of High Risk Clinical Target Volume reduction during Brachytherapy and impact on its coverage in patients with inoperable cervical cancer.
Pobijakova M; Scepanovic D; Paluga M; Fekete M; Mardiak J
Neoplasma; 2018 Mar; 65(3):425-430. PubMed ID: 29788726
[TBL] [Abstract][Full Text] [Related]
4. Development and dosimetric assessment of a patient-specific elastic skin applicator for high-dose-rate brachytherapy.
Park SY; Kang S; Park JM; An HJ; Oh DH; Kim JI
Brachytherapy; 2019; 18(2):224-232. PubMed ID: 30528742
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of a 3D-printed applicator for vaginal brachytherapy in patients with central pelvic-recurrent cervical cancer after primary hysterectomy.
Qin X; Zhang F; Hou X; Yu L; Yu L; Yan J; Qiu J
Brachytherapy; 2022; 21(2):193-201. PubMed ID: 34980568
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Dosimetric Influence of Applicator Displacement on 2D and 3D Brachytherapy for Cervical Cancer Treatment.
Wu A; Tang D; Wu A; Liu Y; Qian L; Zhu L
Technol Cancer Res Treat; 2021; 20():15330338211041201. PubMed ID: 34569371
[TBL] [Abstract][Full Text] [Related]
7. Clinical applications of 3-dimensional printing in radiation therapy.
Zhao Y; Moran K; Yewondwossen M; Allan J; Clarke S; Rajaraman M; Wilke D; Joseph P; Robar JL
Med Dosim; 2017 Summer; 42(2):150-155. PubMed ID: 28495033
[TBL] [Abstract][Full Text] [Related]
8. Can MRI-only replace MRI-CT planning with a titanium tandem and ovoid applicator?
Harkenrider MM; Patel R; Surucu M; Chinsky B; Mysz ML; Wood A; Ryan K; Shea SM; Small W; Roeske JC
Brachytherapy; 2018; 17(5):747-752. PubMed ID: 29945764
[TBL] [Abstract][Full Text] [Related]
9. Point A vs. HR-CTV D
Harmon G; Diak A; Shea SM; Yacoub JH; Small W; Harkenrider MM
Brachytherapy; 2016; 15(6):825-831. PubMed ID: 27693173
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
Beriwal S; Kim H; Heron DE; Selvaraj R
Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
[TBL] [Abstract][Full Text] [Related]
11. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study.
Charra-Brunaud C; Harter V; Delannes M; Haie-Meder C; Quetin P; Kerr C; Castelain B; Thomas L; Peiffert D
Radiother Oncol; 2012 Jun; 103(3):305-13. PubMed ID: 22633469
[TBL] [Abstract][Full Text] [Related]
12. A novel two-step optimization method for tandem and ovoid high-dose-rate brachytherapy treatment for locally advanced cervical cancer.
Sharma M; Fields EC; Todor DA
Brachytherapy; 2015; 14(5):613-8. PubMed ID: 26092424
[TBL] [Abstract][Full Text] [Related]
13. Custom 3D-printed applicators for high dose-rate brachytherapy in skin cancer.
Membrive Conejo I; Pera Cegarra O; Foro Arnalot P; Reig Castillejo A; Rodríguez de Dios N; Sanz Latiesas X; Pujol Vallverdú RM; Quera Jordana J; Fernandez-Velilla Cepria E; Algara Muñoz V; Algara López M
Brachytherapy; 2021; 20(6):1257-1264. PubMed ID: 34384694
[TBL] [Abstract][Full Text] [Related]
14. Pilot study in the treatment of endometrial carcinoma with 3D image-based high-dose-rate brachytherapy using modified Heyman packing: clinical experience and dose-volume histogram analysis.
Weitmann HD; Pötter R; Waldhäusl C; Nechvile E; Kirisits C; Knocke TH
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):468-78. PubMed ID: 15890589
[TBL] [Abstract][Full Text] [Related]
15. Can we reduce dose to ureters as avoidance organs for MRI based brachytherapy for cervical cancer? A dosimetric feasibility study.
Koerner SA; Baig T; Kim H; Rodríguez-López J; Keller A; Beriwal S
Brachytherapy; 2022; 21(2):202-207. PubMed ID: 34980569
[TBL] [Abstract][Full Text] [Related]
16. Introduction of novel 3D-printed superficial applicators for high-dose-rate skin brachytherapy.
Jones EL; Tonino Baldion A; Thomas C; Burrows T; Byrne N; Newton V; Aldridge S
Brachytherapy; 2017; 16(2):409-414. PubMed ID: 27965116
[TBL] [Abstract][Full Text] [Related]
17. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of two-dimensional radiography and three dimensional computed tomography based dose-volume parameters for high-dose-rate intracavitary brachytherapy of cervical cancer: a prospective study.
Madan R; Pathy S; Subramani V; Sharma S; Mohanti BK; Chander S; Thulkar S; Kumar L; Dadhwal V
Asian Pac J Cancer Prev; 2014; 15(11):4717-21. PubMed ID: 24969909
[TBL] [Abstract][Full Text] [Related]
19. Computed tomography-based three-dimensional dosimetry of intracavitary brachytherapy for cervical cancer.
Wadasaki K; Monzen Y; Kurose T; Okazaki H; Mito M
Jpn J Radiol; 2010 Dec; 28(10):740-5. PubMed ID: 21191739
[TBL] [Abstract][Full Text] [Related]
20. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
